Ensho Therapeutics, Inc.

CIK 2032849 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ensho Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 9, 2026D0002032849-26-000001
Sep 12, 2025D0002032849-25-000003
Nov 12, 2024D0002032849-24-000002
Aug 6, 2024D0002032849-24-000001